Loestrin 24 Fe, Benicar Paragraph IV Certifications Filed
This article was originally published in The Pink Sheet Daily
Executive Summary
The first ANDA with a Paragraph IV certification for Warner Chilcott's oral contraceptive Loestrin 24 Fe (noethindrone acetate/ethinyl estradiol and ferrous fumarate) was submitted April 17, according to FDA's June 22 updated list of filings